[Molecular and biochemical principles of neoplasm enzyme therapy]

Biomeditsinskaia Khimiia
|August 18, 2005
PubMed

Insights

Bacterial enzymes show promise as novel anti-cancer agents. Studies demonstrate the tumor-inhibiting effects of glutaminase, methionine gamma-lyase, and lysine alpha-oxidase, suggesting their potential in oncology.

Area of Science:

  • Biochemistry
  • Oncology
  • Enzymology

Background:

  • Tumor enzyme therapy exploits biochemical differences between normal and cancer cells.
  • Cancer cells often have a higher dependency on specific amino acids for growth.

Discussion:

  • Three bacterial enzymes—glutamine (asparagin)ase, methionine gamma-lyase, and lysine alpha-oxidase—exhibited significant anti-tumor activity.
  • These enzymes were tested in vitro and in vivo across multiple tumor cell lines.
  • Their mechanism involves targeting essential amino acid pathways critical for tumor proliferation.

Key Insights:

  • Bacterial enzymes offer a targeted approach to cancer treatment.
  • Demonstrated efficacy in preclinical models supports their therapeutic potential.
  • Exploiting amino acid auxotrophy in cancer cells is a viable therapeutic strategy.

Outlook:

  • Commercial production of standardized bacterial enzyme preparations is feasible.
  • Rational application of these enzymes could lead to new potent anti-cancer drugs.
  • Further research may integrate these enzymes into existing oncology treatment protocols.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...